HOMOLOGOUS RECOMBINATION REPAIR TESTING PATTERNS AND BARRIERS IN METASTATIC HORMONE-SENSITIVE AND METASTATIC CASTRATION-RESISTANT PROSTATE CANCER ACROSS EUROPE: A REAL-WORLD SURVEY

被引：0
|
作者：
Castro, E. [1 ]
Orji, C. [2 ]
Ribbands, A. [3 ]
Butcher, J. [3 ]
Walley, M. [4 ]
Li, W. [5 ]
Ghate, S. [2 ]
机构：
[1] Hosp Univ 12 Octubre, Madrid, Spain
[2] Merck & Co Inc, Rahway, NJ USA
[3] Adelphi Real World, Bollington, Cheshire, England
[4] Adelphi Real World, Macclesfield, Cheshire, England
[5] AstraZeneca Pharmaceut LP, Gaithersburg, MD USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD8
引用
收藏
页码：S222 / S222
页数：1
相关论文
共 50 条
  • [1] Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan
    Leith, Andrea
    Ribbands, Amanda
    Kim, Jeri
    Last, Matthew
    Barlow, Sophie
    Yang, Lingfeng
    Ghate, Sameer R.
    FUTURE ONCOLOGY, 2022, 18 (08) : 937 - 951
  • [2] REAL-WORLD TREATMENT PATTERNS IN THE METASTATIC HORMONE-SENSITIVE PROSTATE CANCER SETTING ACROSS EUROPE
    Castro, E.
    Orji, C.
    Ribbands, A.
    Butcher, J.
    Walley, M.
    Li, W.
    Ghate, S.
    VALUE IN HEALTH, 2024, 27 (06) : S231 - S232
  • [3] Real-world genetic testing patterns in metastatic castration-resistant prostate cancer
    Shore, Neal
    Ionescu-Ittu, Raluca
    Yang, Lingfeng
    Laliberte, Francois
    Mahendran, Malena
    Lejeune, Dominique
    Yu, Louise
    Burgents, Joseph
    Duh, Mei Sheng
    Ghate, Sameer R.
    FUTURE ONCOLOGY, 2021, 17 (22) : 2907 - 2921
  • [4] Real-world treatment patterns and genetic testing in a metastatic castration-resistant prostate cancer setting in Europe
    Castro, Elena
    Orji, Chinelo
    Ribbands, Amanda
    Butcher, Jake
    Walley, Maria
    Li, Weiyan
    Ghate, Sameer R.
    FUTURE ONCOLOGY, 2025,
  • [5] Real-world biomarker testing patterns in metastatic castration-resistant prostate cancer patients
    Blanc, Simon
    Adeboyeje, Gboyega
    Lee, Liam
    Gart, Mike
    Saunders, William
    Wang, Brandon
    Dave, Poras
    English, Sandy
    Varughese, Prateesh
    Sillah, Arthur
    CANCER RESEARCH, 2023, 83 (07)
  • [6] REAL-WORLD TREATMENT PATTERNS AND TREATMENT SEQUENCES IN THE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER SETTINGS ACROSS EUROPE
    Castro, E.
    Orji, C.
    Ribbands, A.
    Butcher, J.
    Walley, M.
    Li, W.
    Ghate, S.
    VALUE IN HEALTH, 2024, 27 (06) : S227 - S227
  • [7] Real-world homologous recombination repair mutation (HRRm) testing patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in the United States
    George, Daniel J.
    Kariburyo-Yay, Furaha
    Aggarwal, Himani
    Tepsick, Jon G.
    Yu, Rebekah
    Li, Weiyan
    McLaurin, Kimmie K.
    Orji, Chinelo
    Lal, Lincy S.
    Ghate, Sameer R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 332 - 332
  • [8] Exploiting defects in homologous recombination repair for metastatic, castration-resistant prostate cancer
    Chau, Vincent
    Madan, Ravi A.
    Figg, William D.
    CANCER BIOLOGY & THERAPY, 2020, 21 (10) : 884 - 887
  • [9] Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer
    Halwani, Ahmad S.
    Rasmussen, Kelli M.
    Patil, Vikas
    Li, Catherine C.
    Yong, Christina M.
    Burningham, Zachary
    Gupta, Sumati
    Narayanan, Sujata
    Lin, Shih-Wen
    Carroll, Susheela
    Mhatre, Shivani K.
    Graff, Julie N.
    Dreicer, Robert
    Sauer, Brian C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (01) : 1.e1 - 1.e10
  • [10] Homologous recombination repair gene mutation (HRRm) testing patterns and treatment selection from a real-world cohort of patients with metastatic castration-resistant prostate cancer (mCRPC).
    Shore, Neal D.
    Craver, Christopher
    Blanc, Simon
    Sathyan, Pratheesh
    Aton, Lindsay
    Varughese, Prateesh
    Tierno, Marni Brisson
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 210 - 210
12345